Pustular lesions in patients with Crohn disease and treatment with tumour necrosis factor‐α inhibitors

We present seven new cases of patients with Crohn disease who developed lesions clinically compatible with amicrobial pustulosis of the flexures during their treatment with anti‐tumour necrosis factor therapy.

Saved in:

Bibliographic Details
Published in	Clinical and experimental dermatology Vol. 47; no. 2; pp. 453 - 455
Main Authors	Balaguer‐Franch, I., Hernández de la Torre‐Ruiz, E., Lacasta‐Plasin, C., García‐Piqueras, P., Menchén‐Viso, L., Baniandrés‐Rodríguez, O.
Format	Journal Article
Language	English
Published	England Oxford University Press 01.02.2022
Subjects	Adalimumab - adverse effects Adult Crohn Disease - complications Crohn Disease - drug therapy Crohn's disease Female Humans Infliximab - adverse effects Male Middle Aged Patients Pustulosis Skin Diseases, Vesiculobullous - chemically induced Skin Diseases, Vesiculobullous - pathology Tumor necrosis factor Tumor Necrosis Factor Inhibitors - adverse effects Tumor Necrosis Factor-alpha - antagonists & inhibitors Tumor necrosis factor-TNF Tumors
Online Access	Get full text
ISSN	0307-6938 1365-2230 1365-2230
DOI	10.1111/ced.14909

Cover

More Information
Summary:	We present seven new cases of patients with Crohn disease who developed lesions clinically compatible with amicrobial pustulosis of the flexures during their treatment with anti‐tumour necrosis factor therapy.
Bibliography:	Conflict of interest: the authors declare that they have no conflicts of interest. SourceType-Scholarly Journals-1 content type line 14 ObjectType-Editorial-2 ObjectType-Commentary-1 ObjectType-Case Study-2 ObjectType-Correspondence-3 content type line 23 ObjectType-Report-1
ISSN:	0307-6938 1365-2230 1365-2230
DOI:	10.1111/ced.14909